Method for regulating and controlling aggregation state of human islet protein and medicine for treating and preventing type 2 diabetes mellitus
A technology of protein aggregation and islets, which is applied in drug combination, metabolic diseases, active ingredients of anhydride/acid/halide, etc., can solve problems such as out-of-control blood sugar regulation, achieve the effect of improving survival rate, reducing survival time, and improving survival rate
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- Publication Date
- 2020-04-21
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
Technical Field
[0001] The invention relates to a method for regulating the aggregation state of human islet protein and a treatment and preventive medicine for type 2 diabetes, belonging to the field of biological protein regulation.
Background technique
[0002] Amyloid aggregates (Amyloid) is an insoluble fibrous protein. If it accumulates abnormally in organs, it will cause amyloidosis. In many neurological diseases, such as Alzheimer's disease, Parkinson's disease and type II diabetes, a large amount of amyloid fiber accumulation can be observed in the system. Most scholars believe that it may cause degeneration or dysfunction of the brain or other related organs. The production of amyloid aggregates undergoes a process from monomers to oligomers. This process is called the nucleation period. Then the oligomers aggregate to form precursor fibers, and then rapidly form fibers, finally reaching stable mature fibers. Since the whole process is irreversible, it becomes ex...
Examples
Embodiment
[0030] This embodiment provides a method for regulating the aggregation state of human insulin, including the following steps:
[0031] 1. Mix the fast green powder and deionized water ultrasonically and shake for 1 minute under 200w conditions to form a 1 mM fast green solution;
[0032] 2. Mix hIAPP with phosphate buffered saline solution to form a 500μM protein solution;
[0033] 3. Add deionized water to the protein solution and dilute with shaking to reduce the concentration of the protein solution to 50μM;
[0034] 4. Divide the 1mM fast green solution into three parts, and then dilute them into 8μM, 80μM and 800μM fast green solutions;
[0035] 5. Take out 40 μL from the protein solution, and then add 40 μL of deionized water to form a blank group with a hIAPP concentration of 25 μM;
[0036] 6. Take out 40μL from the protein solution, and then add 40μL of 8μM fast green solution to form sample 1 with hIAPP concentration of 25μM and fast green concentration of 4μM;
[0037] 7. Take...